AbbVie (ABBV)

$106.23 0.33 (0.31%)

7:11 EDT ABBV Stock Quote Delayed 30 Minutes

7 Cutting-Edge Biotech Stocks for Tomorrow

By Bret Kenwell, InvestorPlace Contributor Oct 28, 2020

Biotech stocks are always going to be here, in good times and bad. Let's look at a few that are worth considering on the long side.

7 Dividend Stocks To Buy For Big Returns In Your Bank Account

5 High-Yield Stocks for 5%-Plus Dividend Payouts

7 Value Stocks To Buy in an Overvalued Market

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 731

Day's Range 105.90 - 105.90

52-Week Range 79.11 - 113.41

Dividend & Yield 5.20 (4.90%)

ABBV Stock Predictions, Articles, and AbbVie News

From InvestorPlace
From the Web

7 Dividend Stocks Perfect for a Retiree’s Portfolio

By Chris Lau, InvestorPlace Contributor Oct 1, 2020

Chasing high yields alone will ruin an income investor’s returns, so we look at these picks that offer a balance of stability and dividend income growth.

7 Undervalued Stocks With Massive Potential

By Chris Lau, InvestorPlace Contributor Sep 21, 2020

The stock market may have forgotten about these seven undervalued stocks, but you can pick them up now on the cheap.

6 Dividend Stocks To Buy For Stable Yield And Growth Potential

By Alex Sirois Sep 17, 2020

Juicy dividends or explosive growth stocks? Most investors don't want to choose. Here are 6 dividend stocks to keep both sides happy.

Great Yield and Packed Pipeline Signal a Buy for AbbVie

By David Moadel, InvestorPlace Contributor Sep 15, 2020

Investors can still own AbbVie stock at a good price, even in the wake of a potentially lifesaving collaboration.

30 Dividend Stocks to Buy Now for 20 Years of Income Growth

By Josh Enomoto, InvestorPlace Contributor Aug 26, 2020

With a 20-year timeline, you have multiple choices for dividend stocks to buy. Here are 30 names that should do very well.

6 Marijuana Stocks to Buy That Are Sticking In the Green

By Alex Sirois Aug 25, 2020

You can find the best marijuana stocks to buy by considering their revenue rather than chasing pure hype. Here are six that fit the bill.

7 Hot Stocks to Buy Before It’s Too Late

By Chris Lau, InvestorPlace Contributor Aug 25, 2020

Hot stocks are easy to find, but if you wait too long to buy them, you will have big regrets. Buy these seven stocks before it's too late.

AbbVie Earnings: ABBV Stock Drops 2% Despite Q2 Beats

By Nick Clarkson, Web Editor Jul 31, 2020

AbbVie earnings on Friday have ABBV stock slighty lower despite the company beating EPS and revenue estimates from Wall Street.

5 High-Yield Drug Stocks That Are Undervalued With Great Upside

By Mark R. Hake, CFA Jul 24, 2020

As the market continues to deal with the pandemic, these five cheap drug stocks have solid dividend yields of 4% and almost 37% upside.

The 8 Most Reliable Blue-Chip Stocks In the Market Today

By Gregg Early, InvestorPlace Contributor Jul 23, 2020

Fortunately, with these strong blue-chip stocks, buying safety doesn’t mean you’re going to miss out on growth. Here's why.

The 7 Best Pharmaceutical Stocks That Go Beyond the Covid-19 Chase

By Louis Navellier and the InvestorPlace Research Staff, Editor, Growth Investor Jul 14, 2020

There’s a select group of pharmaceutical stocks that stand to win without even looking for a Covid-19 cure.

AbbVie Remains One of the Safest Pharma Investments You Can Make

By Louis Navellier and the InvestorPlace Research Staff, Editor, Growth Investor Jul 8, 2020

The pharmaceutical market has its ups and downs, but that doesn't mean every investment is risky as ABBV stock is a reasonably safe bet.

4 Top Stock Trades for Wednesday: LVGO, WMT, ABBV, NVAX

By Bret Kenwell, InvestorPlace Contributor Jul 7, 2020

AbbVie, Livongo, Walmart and Novavax were our top stock trades for Wednesday. That said, let's look at the charts to see what's going on.

AbbVie Stands to Benefit from Affluenza

By Josh Enomoto, InvestorPlace Contributor Jul 7, 2020

With another wave of coronavirus cases hitting the U.S., AbbVie stock seems a dubious investment. Yet with the acquisition of Allergan and its Botox treatment, ABBV has long-term upside potential.

AbbVie Is Cheap and Pays an Attractive Yield

By Mark R. Hake, CFA Jul 2, 2020

AbbVie stock is both cheap and has an attractive dividend yield. AbbVie stock sells below 10x earnings, with a 4.9% dividend yield and a 28% upside target value.

7 of the Best Blue-Chip Stocks to Buy

By Chris Lau, InvestorPlace Contributor Jun 8, 2020

Investors need to differentiate between speculative stocks rising higher than ever and proven blue-chip stocks, and stick to the latter.

Abbvie Stock is Offering Investors an Oil Yield Without Oil’s Risk

By Dana Blankenhorn, InvestorPlace Contributor Jun 3, 2020

Analysts call ABBV stock a bargain after its $63 billion purchase of Allergan, whose existing drugs and pipeline are now expected to replace revenue from Humira.

AbbVie Will Be in Big Trouble When Its Patent Cliff Arrives

By Ian Bezek, InvestorPlace Contributor Jun 2, 2020

ABBV stock may seem like an attractive value name. But while it is very profitable now, things are set to worsen dramatically in a few years..

AbbVie Stock Is More Than a Great Dividend Payer

By Louis Navellier and the InvestorPlace Research Staff, Editor, Growth Investor Jun 2, 2020

It's fine if you want to hold ABBV stock for the dividend payouts, but there are also other reasons to own it.

AbbVie Stock Is a Winner in the Pharmaceutical Industry

By Divya Premkumar, InvestorPlace Contributor Jun 2, 2020

The public health crisis threw AbbVie into the spotlight but the company handled the ongoing crisis better than its competitors. With a successful acquisition and a high dividend yield. ABBV stock is a safe bet for investors in a volatile market.